Disease/Condition

127 Clinical Trials

10+ Countries

Renal Impairment Clinical Trials Database - Free Access to 127 Studies

Access comprehensive clinical trial information for Renal Impairment through Pure Global AI's free database. This collection includes 127 clinical trials across multiple phases including Phase 1, N/A, Phase 4. Currently, 21 trials are actively recruiting participants.

Research for Renal Impairment is being conducted in United States of America, Germany, China and 7+ other countries. Leading sponsors include Novartis Pharmaceuticals and Pfizer. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Free Database

840K+ Global Trials

Updated Daily

By Phase

Phase 1

116

N/A

Phase 4

Phase 2

Early Phase 1

By Status

Completed

Recruiting

Not yet recruit...

Terminated

Enrolling by in...

Top Countries

United States of America65

Germany14

China6

New Zealand,United States of America2

Canada2

Top Sponsors

Novartis Pharmaceu...12

Pfizer10

AstraZeneca5

Sanofi4

Merck Sharp & Dohm...4

Recent Trials

Latest clinical trials for Renal Impairment

Renal Impairment Clinical Trials Database - Free Access to 127 Studies

Assessment of Renal Function by Multiparametric MRI

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Multiple Oral Doses (6 Days) of 100 mg Resmetirom in Subjects With Severe Renal Impairment and in Matched Healthy Control Subjects With Normal Renal Function

A Study to Evaluate the Drug Levels of Mezigdomide in Adult Participants With Renal Impairment

A Study of MK-8527 in Participants With Moderate and Severe Renal Impairment (MK-8527-008)

A Study to Learn How the Body Processes the Study Medicine Called PF-07923568 in People With Loss of Kidney Function

A Study to Evaluate Pharmacokinetic and Safety Trial of Emraclidine in Participants With Renal Impairment Compared With Participants With Normal Renal Function

A Study to Evaluate the Pharmacokinetics of HSK21542 in Subjects With Renal Impairment

A Study to Test How Kidney Problems Influence the Blood Concentrations of Efgartigimod

A Study to Evaluate the Pharmacokinetics of HSK16149 in Subjects With Renal Impairment

Study of GBT021601 in Participants With Renal Impairment

A Study to Evaluate Pharmacokinetics (PK) and Safety of Inaxaplin in Participants With Renal Impairment

A Study to Investigate the Effect of Renal Impairment on the Pharmacokinetics and Safety of VIR-2218

Pharmacokinetics of IBI362 in Subjects With and Without Renal Impairment

A Study of Brensocatib Following a Single Oral Administration in Participants With or Without Renal Impairment

Phase 1 PK Study to Assess Safety, PK, Tolerability of HM15912 in Subjects With Renal Impairment and Normal Renal Function

Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics of a Single 3 mg Cytisinicline Dose

Role Of Serum Adiponectin In The Ealy Detection Of Renal Impairment In Patients With Non Alcoholic Fatty Liver Disease

Pharmacokinetics Study of TNO155 in Participants With Mild, Moderate, or Severe Renal Impairment Compared to Matched Healthy Participants

Pharmacokinetics of Chiglitazar in Subjects With Renal Impairment and Normal Renal Function

A Study to Evaluate the Pharmacokinetics of HSK7653 in Subjects With Renal Impairment

DJ Fang